The inaugural PouchEx 2025 conference, dedicated exclusively to nicotine pouches, was a niche event...
3 minute read
Last week’s announcement from FDA regarding the authorization of on! PLUS was very encouraging. With more authorizations likely soon, a greater focus on enforcement, and the rejection of frivolous applications, a market can be created that rewards...
Filter
Filter
3 minute read
The inaugural PouchEx 2025 conference, dedicated exclusively to nicotine pouches, was a niche event...
The 2025 Food and Drug Law Institute (FDLI) Tobacco and Nicotine Conference delivered something the...
6 minute read
When FDA deployed the “fatal flaw” concept during ENDS PMTA reviews, it was seen by many as a...
2 minute read
The 2025 Global Tobacco and Nicotine Forum (GTNF), held in Brussels, brought together policymakers,...
EVO NXT 2025 in Milan offered a refreshing departure from traditional large-scale expos. The event...
1 minute read
The nicotine pouch market in the US is growing rapidly, but so is regulatory scrutiny. The FDA’s...
4 minute read
Examining the legal frameworks for new analogues
On January 16, 2025, the FDA granted marketing authorisation for Swedish Match’s Zyn nicotine...
The Keller and Heckman LLP E-Vapor and Tobacco Law Symposium provided in-depth discussions on the...
Ensure your business stays ahead of the competition by keeping up to date on the latest regulatory changes. Sign up for our newsletter to have the latest information and insights served directly to your inbox.